Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

Recruitment is underway for a clinical trial testing a vaccine candidate produced with The University of Queensland's ...

and founding investor Medicxi – will go in part towards clinical testing of Vicebio's lead vaccine VXB-241 for respiratory syncytial virus (RSV) and human metapneumovirus (hMPV), which is in ...

A COVID-19 vaccine developed using the technology cleared a phase 1 proof-of-concept study in Australia, but Vicebio is focusing first on RSV, with clinical trials of VXB-211 scheduled to in the ...

Vaccines developer Vicebio unveiled $100 million in financing as it begins a Phase 1 test of VXB-241, a bivalent vaccine designed to address both respiratory syncytial virus (RSV) )and human ...

But with respiratory syncytial virus, or RSV, how old you are can affect how sick you get. “Respiratory syncytial virus does present differently in folks of different ages,” says Kisha Davis ...

Pregnant mothers and newborn babies in every state will have access to free vaccines for RSV before next winter. Federal Health Minister Mark Butler said 12,000 babies are admitted to hospital ...